Home > Products > CD3 & PD1
> Recombinant Anti-CD3 x Anti-PD1 Bispecific Antibody (scDiabody-Fc)
Recombinant Anti-CD3 x Anti-PD1 Bispecific Antibody (scDiabody-Fc) (CAT#: SCDBF-098)
Recombinant Anti-CD3 x Anti-PD1 Bispecific Antibody (scDiabody-Fc) is a fusion protein of two scDiabodies with an Fc region. In single-chain Diabodies, an additional connecting linker is introduced between chains of the anti-CD3/anti-PD1 diabody. The scDiabody with two specificities is further fused to the Fc domain to form BsAb with 2+2 antigen-binding valency. This BsAb can retarget T cells to tumor cells. It is designed for the research of Esophageal cancer; Hodgkin lymphoma; Renal cell cancer (RCC); Mesothelioma; Head and neck squamous cell cancer (HNSCC); Anal cancer; Gastric cancer; Hepatocellular cancer; Nasopharyngeal cancer; Non-small cell lung cancer (NSCLC); Solid tumors therapy.
There are currently no customer reviews or questions for Recombinant Anti-CD3 x Anti-PD1 Bispecific Antibody (scDiabody-Fc) (SCDBF-098). Click the button below to contact us or submit your feedback about this product.